DJI46,918.03+0.77%
GDAXI23,564.01+0.50%
GSPC6,698.10+0.99%
HSI25,834.02+1.45%
IXIC22,382.78+1.25%
N22553,751.15-0.13%
AAPL252.59+0.99%
AMZN209.95+1.10%
CL94.33-4.44%
EURUSD1.1500+0.67%
GBPUSD1.3308+0.64%
GC4,994.70-1.32%
GOOG303.37+0.63%
JPM285.44+0.71%
META624.54+1.85%
MSFT398.47+0.74%
NVDA184.38+2.29%
TSLA397.08+1.50%
DJI46,918.03+0.77%
GDAXI23,564.01+0.50%
GSPC6,698.10+0.99%
HSI25,834.02+1.45%
IXIC22,382.78+1.25%
N22553,751.15-0.13%
AAPL252.59+0.99%
AMZN209.95+1.10%
CL94.33-4.44%
EURUSD1.1500+0.67%
GBPUSD1.3308+0.64%
GC4,994.70-1.32%
GOOG303.37+0.63%
JPM285.44+0.71%
META624.54+1.85%
MSFT398.47+0.74%
NVDA184.38+2.29%
TSLA397.08+1.50%
DJI46,918.03+0.77%
GDAXI23,564.01+0.50%
GSPC6,698.10+0.99%
HSI25,834.02+1.45%
IXIC22,382.78+1.25%
N22553,751.15-0.13%
AAPL252.59+0.99%
AMZN209.95+1.10%
CL94.33-4.44%
EURUSD1.1500+0.67%
GBPUSD1.3308+0.64%
GC4,994.70-1.32%
GOOG303.37+0.63%
JPM285.44+0.71%
META624.54+1.85%
MSFT398.47+0.74%
NVDA184.38+2.29%
TSLA397.08+1.50%
CYBERETIKAGLOBAL FINANCIAL INTELLIGENCE
LIVE
CAN Financial Post EN

NervGen Pharma Announces Voluntary Delisting from TSX Venture Exchange

The Company’s common shares will continue to trade on Nasdaq under the symbol “NGEN” No action is required; all shareholders, including Canadian shareholders, will continue to maintain full trading access on Nasdaq VANCOUVER, British Columbia, March 12, 2026 (GLOBE NEWSWIRE) — NervGen Pharma Corp. (“NervGen” or the “Company”) (TSXV: NGEN) (NASDAQ: NGEN), a clinical-stage biopharmaceutical […]

Mar 12, 2026 &03191212202631; 20:19 UTC financialpost.com Trending 2/5
Read original on financialpost.com ↗
→
Neutral impact
Sentiment score: 0/100
Low impact Immediate effect (hours)
WHAT THIS MEANS
NervGen Pharma voluntarily delists from TSX Venture Exchange while maintaining Nasdaq listing under ticker NGEN. The move simplifies the company's listing structure with no impact on shareholder trading access, as Canadian shareholders retain full trading capability on Nasdaq.
AI CONFIDENCE
75% High
SENTIMENT GAUGE
NEWS POWER SCORE
AFFECTED ASSETS
⇅
NGEN
NGENStock
High volatility expected
Delisting from TSX Venture may cause short-term trading volatility as positions consolidate on Nasdaq; no fundamental business impact
↓
TSXV
TSXVIndex
Expected to decline
Minor negative impact from removal of listed security from TSX Venture index
PRICE HISTORY
Loading chart...
⚡ SUGGESTED ACTION
Monitor NGEN trading volume on Nasdaq for potential liquidity shifts post-delisting. The move is administratively neutral for shareholders but may create short-term price volatility as dual-listing arbitrage opportunities disappear.
KEY SIGNALS
Voluntary delisting indicates strategic simplificationNasdaq remains primary trading venueNo shareholder action requiredLiquidity consolidation on single exchange
SECTORS INVOLVED
BiopharmaceuticalHealthcare
Analysis generated on Mar 16, 2026 at 16:21 UTC
Disclaimer: This analysis is generated by artificial intelligence for informational purposes only and does not constitute financial advice, investment recommendation, or solicitation. Original reporting by Financial Post. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

RELATED INTELLIGENCE

Middle East oil exports drop at least 60% as Strait of Hormuz stays mostly closed, data shows
BNN Bloomberg Mar 16, 21:13 Negative
Bell plans $1.7B AI data centre in Saskatchewan as demand for computing power surges
BNN Bloomberg Mar 16, 21:03 Positive
Urbana Corporation Intersects 4.2 g/t Au over 10 Metres and Begins Second Drill Program
BNN Bloomberg Mar 16, 20:59 Positive
Surging gas prices threaten to reverse Canada’s inflation progress, economists say
BNN Bloomberg Mar 16, 20:46 Negative
Market Outlook: Iran conflict and oil surge raise stakes before U.S. Fed
BNN Bloomberg Mar 16, 20:43 Negative